Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis
Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis have?
Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis has 39 citations in the OpenAlex counts PICO Portal stores.
When was Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis published?
Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis has 2020 year in the PICO Portal index.
What is the open-access status of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?
Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis has closed oa status in the PICO Portal index.
What is the DOI of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?
The DOI for Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.
What is the PMID of Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?
The PMID for Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.
What is the OpenAlex record for Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis?
The OpenAlex for Comparison of tenofovir <i>versus</i> entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis is on the source record.